Target intelligence / Profile preview

Serotonin transporter and Norepinephrine transporter (SERT and NET)

Target
SERT and NET
Molecular classification
Transporter, Sodium-dependent neurotransmitter transporters, Solute carrier family
01

Overview

Serotonin transporter (SERT) and Norepinephrine transporter (NET) are integral membrane proteins that facilitate the sodium- and chloride-dependent transport of released serotonin and norepinephrine, respectively, from the synaptic cleft back into presynaptic nerve terminals. These transporters play key roles in regulating neurotransmitter levels in the brain, which affects mood, sleep, pain perception, and various other physiological functions. The NET is encoded by the SLC6A2 gene located on human chromosome 16 and consists of 617 amino acids with 12 membrane-spanning domains. Both transporters show some promiscuity in their function, with NET capable of reuptaking dopamine in addition to norepinephrine, and SERT showing evidence of dopamine uptake under certain conditions. These transporters are important therapeutic targets for treating depression, anxiety disorders, ADHD, and chronic pain conditions. Drugs targeting these transporters work by blocking the reuptake process, thereby increasing neurotransmitter availability in the synaptic cleft. The selectivity of inhibitors for SERT versus NET is determined by specific residues within the S1 binding pocket of these transporters. Interestingly, drugs that target both transporters (SNRIs) or multiple monoamine transporters often show improved clinical efficacy compared to highly selective agents, suggesting that the natural promiscuity of these transporters may have therapeutic relevance.

Other names
Serotonin transporter (SERT)Norepinephrine transporter (NET)Noradrenaline transporter (NAT)Solute carrier family 6 member 2 (SLC6A2) for NET
02

Mechanism of action

Drugs targeting these transporters block the reabsorption (reuptake) of serotonin and/or norepinephrine from the synaptic cleft back into presynaptic neurons. This increases the concentration and availability of these neurotransmitters in the synaptic cleft, which helps ease symptoms associated with their deficiency. Selectivity varies among different drug classes (SSRIs, NRIs, SNRIs). Binding occurs within the central S1 pocket of the transporters.

03

Biological functions

Reuptake of neurotransmitters (serotonin and norepinephrine) from the synaptic cleft back into presynaptic nerve terminalsRegulation of neurotransmitter concentrations in the synaptic cleftSpatiotemporal regulation of serotonin and norepinephrine neurotransmissionMaintenance of extrasynaptic monoamine levelsPre-synaptic monoamine homeostasisRegulation of mood, sleep, pain, appetite, aggression, and sexual activity
04

Disease associations

Depression and anxiety disordersAttention-deficit hyperactivity disorder (ADHD)Chronic neuropathic pain and fibromyalgia syndromeObsessive-compulsive disorder (OCD)Menopausal symptoms
05

Safety considerations

Serotonin syndrome (dangerously high serotonin levels)Increased risk of suicidal thoughts or behavior in children, teenagers, and young adults under 25Side effects including nausea, insomnia, and other adverse reactionsDrug interactions, particularly with other serotonergic medications
06

Interacting drugs

Selective serotonin reuptake inhibitors (SSRIs)

15 more in the full profile.

Beyond the preview

Go deeper on Serotonin transporter and Norepinephrine transporter (SERT and NET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonin transporter and Norepinephrine transporter (SERT and NET).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call